AIMD vs MLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

AIMD

39.8
AI Score
VS
AIMD Wins

MLAB

37.9
AI Score

Investment Advisor Scores

AIMD

40score
Recommendation
AVOID NEW MONEY

MLAB

38score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric AIMD MLAB Winner
Forward P/E 13.9082 35.2113 AIMD
PEG Ratio 0.9278 0 Tie
Revenue Growth -96.7% 2.6% MLAB
Earnings Growth 0.0% 67.0% MLAB
Tradestie Score 39.8/100 37.9/100 AIMD
Profit Margin 0.0% 2.6% MLAB
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED MLAB

Relative Price Performance (Last 90 Days)

AIMD 1M: +10.4% · 3M: -25.4% MLAB 1M: +7.2% · 3M: +27.5%

Current Technical Phase

AIMD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.2 · Price: $1.06

MLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.6% over 20 days), RSI 57

RSI (14): 56.8 · Price: $135.20

Fundamentals Snapshot

Metric AIMD MLAB
Market Cap — —
Forward P/E 13.9 25.1
Trailing P/E — 120.0
Revenue (TTM) — —
Revenue Growth -1.0% 0.0%
Gross Margin 0.8% 0.6%
Operating Margin -1012.1% 0.1%
EPS -2.54 1.16
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, AIMD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.